SPL 2.33% $1.47 starpharma holdings limited

Sanofi Aventis and Starpharma's Dep Docetaxel

  1. 7,095 Posts.
    lightbulb Created with Sketch. 176
    Starpharma has confidentiality agreements using it's proprietry drug delivery systems with undisclosed major world companies reformulating and developing new drugs in oncology .

    It would not surprise me if one of these undisclosed commercial partners is Sanofi Aventis

    I believe it is just a few short moments away from substantial can't get enough of Starpharma stock herd mentality.

    Those that have been patient for such a long time - reward is just around the corner

    The above statements are my opinion and should not be construed as investment advice


    Here is a link for those wishing to pursue my line of reasoning and comment further


    http://en.wikipedia.org/wiki/Docetaxel
    Last edited by antibotter: 16/02/15
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
$1.47
Change
-0.04(2.33%)
Mkt cap $556.8M
Open High Low Value Volume
$1.50 $1.51 $1.46 $238.0K 161.2K

Buyers (Bids)

No. Vol. Price($)
2 12476 $1.46
 

Sellers (Offers)

Price($) Vol. No.
$1.48 2303 1
Last update - 16.10pm 22/10/2018 (20 minute delay) ?
(live)
Last
$1.47
  Change
-0.04 ( 1.09 %)
Open High   Low Volume
$1.50 $1.51   $1.46 51033
Last updated 15.59pm 22/10/2018 (live) ?
SPL (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.